GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Cyclically Adjusted Price-to-FCF

CLS Holdings USA (XCNQ:CLSH) Cyclically Adjusted Price-to-FCF : (As of May. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


CLS Holdings USA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for CLS Holdings USA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Cyclically Adjusted Price-to-FCF Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CLS Holdings USA's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Cyclically Adjusted Price-to-FCF falls into.



CLS Holdings USA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

CLS Holdings USA's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, CLS Holdings USA's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.005/129.4194*129.4194
=-0.005

Current CPI (Feb. 2024) = 129.4194.

CLS Holdings USA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201405 -0.001 100.373 -0.001
201408 -0.030 100.352 -0.039
201411 -0.078 99.635 -0.101
201502 -0.069 99.032 -0.090
201505 -0.055 100.333 -0.071
201508 -0.078 100.548 -0.100
201511 -0.061 100.135 -0.079
201602 -0.106 100.040 -0.137
201605 -0.088 101.355 -0.112
201608 -0.100 101.617 -0.127
201611 -0.088 101.829 -0.112
201702 -0.054 102.779 -0.068
201705 -0.047 103.256 -0.059
201708 -0.028 103.587 -0.035
201711 -0.035 104.072 -0.044
201802 -0.062 105.052 -0.076
201805 -0.053 106.148 -0.065
201808 -0.279 106.383 -0.339
201811 -0.114 106.338 -0.139
201902 -0.171 106.649 -0.208
201905 -0.017 108.048 -0.020
201908 -0.079 108.245 -0.094
201911 -0.038 108.519 -0.045
202002 -0.036 109.139 -0.043
202005 -0.065 108.175 -0.078
202008 -0.033 109.662 -0.039
202011 -0.030 109.793 -0.035
202102 -0.029 110.968 -0.034
202105 -0.022 113.576 -0.025
202108 -0.035 115.421 -0.039
202111 -0.035 117.269 -0.039
202202 -0.041 119.703 -0.044
202205 -0.058 123.323 -0.061
202208 -0.062 124.958 -0.064
202211 -0.008 125.607 -0.008
202302 0.015 126.928 0.015
202305 0.014 128.314 0.014
202308 0.013 129.538 0.013
202311 0.004 129.548 0.004
202402 -0.005 129.419 -0.005

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CLS Holdings USA  (XCNQ:CLSH) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


CLS Holdings USA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.